文献速递肝病消化内镜

脾硬度测量在排除门窦血管性疾病患者高风险静脉曲张中的表现

Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder.
PubMed 文献 · Hepatology · 2024-07-02

本研究在21个VALDIG中心回顾性纳入309例门窦血管性疾病(PSVD)且至少有一项门高压体征的患者,评估脾硬度测量(SSM-VCTE)≤40 kPa联合胆红素<1 mg/dL排除高风险静脉曲张(HRV)的性能。推导队列154例中43%有HRV,该联合标准排除HRV的敏感性为96%,可减少38%的筛查内镜,漏诊HRV 4%,阴性预测值95%;验证队列155例中可减少21%的筛查内镜,漏诊HRV 4%,阴性预测值94%。结论认为该联合标准可识别HRV概率<5%的PSVD患者,从而免于筛查内镜。

要点

  • PSVD合并门高压患者中,SSM-VCTE≤40 kPa且胆红素<1 mg/dL可排除HRV,推导队列敏感性96%。
  • 推导队列该标准可减少38%筛查内镜,漏诊HRV 4%,阴性预测值95%。
  • 验证队列该标准可减少21%筛查内镜,漏诊HRV 4%,阴性预测值94%。

核心结论

  • SSM-VCTE≤40 kPa联合胆红素<1 mg/dL可识别HRV概率<5%的PSVD合并门高压患者,在此类患者中可免于筛查内镜。

研究设计与样本

  • 回顾性纳入21个VALDIG中心PSVD且至少有一项门高压体征、无静脉曲张出血史、在内镜检查前后2年内接受SSM-VCTE的患者,分为推导队列和验证队列。
  • 推导队列154例,验证队列155例,合计309例。

主要发现

  • 推导队列中43%的患者有HRV。
  • 多变量logistic回归分析显示,SSM-VCTE>40 kPa和血清胆红素≥1 mg/dL与HRV相关。
  • 推导队列中SSM-VCTE≤40 kPa联合胆红素<1 mg/dL排除HRV的敏感性为96%,可减少38%的筛查内镜,漏诊HRV 4%,阴性预测值95%。
  • 验证队列中SSM联合胆红素可减少21%的筛查内镜,漏诊HRV 4%,阴性预测值94%。

关键数值与推荐

  • Baveno VII共识建议:代偿期肝硬化患者若VCTE测得的SSM≤40 kPa,因HRV概率低可免于筛查内镜;而所有PSVD患者均需筛查内镜。
  • 推导队列中SSM-VCTE≤40 kPa联合胆红素<1 mg/dL排除HRV的敏感性为96%,阴性预测值95%。
  • 验证队列中SSM联合胆红素排除HRV的阴性预测值为94%。

临床怎么用

  • 对于PSVD合并门高压体征的患者,SSM-VCTE≤40 kPa联合胆红素<1 mg/dL可识别HRV概率<5%者,在此类患者中可免于筛查内镜。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Baveno VII consensus suggests that screening endoscopy can be spared in patients with compensated cirrhosis when spleen stiffness measurement (SSM) by vibration-controlled transient elastography (VCTE) is ≤40 kPa as they have a low probability of high-risk varices (HRV). Conversely, screening endoscopy is required in all patients with porto-sinusoidal vascular disorder (PSVD). This study aimed to evaluate the performance of SSM-VCTE to rule out HRV in patients with PSVD and signs of portal hypertension. APPROACH AND RESULTS: We retrospectively included patients with PSVD, ≥1 sign of portal hypertension, without a history of variceal bleeding, who underwent an SSM-VCTE within 2 years before or after an upper endoscopy in 21 VALDIG centers, divided into a derivation and a validation cohort. One hundred fifty-four patients were included in the derivation cohort; 43% had HRV. By multivariable logistic regression analysis, SSM-VCTE >40 kPa and serum bilirubin ≥1 mg/dL were associated with HRV. SSM-VCTE ≤40 kPa combined with bilirubin <1 mg/dL had a sensitivity of 96% to rule out HRV and could spare 38% of screening endoscopies, with 4% of HRV missed, and a 95% negative predictive value. In the validation cohort, including 155 patients, SSM combined with bilirubin could spare 21% of screening endoscopies, with 4% of HRV missed and a 94% negative predictive value. CONCLUSIONS: This study gathering a total of 309 patients with PSVD showed that SSM-VCTE ≤40 kPa combined with bilirubin <1 mg/dL identifies patients with PSVD and portal hypertension with a probability of HRV <5%, in whom screening endoscopy can be spared.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Moga L, Paradis V, Ferreira-Silva J, et al. Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder. Hepatology. 2024. PMID: 38954825. doi:10.1097/HEP.0000000000001004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。